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Abstract. We describe a fully automatic framework for classification of two types of dementia based on the differences in the
shape of brain structures. We consider Alzheimer’s disease (AD), mild cognitive impairment of individuals who converted
to AD within 18 months (MCIc), and normal controls (NC). Our approach uses statistical learning and a feature space
consisting of projection-based shape descriptors, allowing for canonical representation of brain regions. Our framework
automatically identifies the structures most affected by the disease. We evaluate our results by comparing to other methods
using a standardized data set of 375 adults available from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Our
framework is sensitive to identifying the onset of Alzheimer’s disease, achieving up to 88.13% accuracy in classifying MCIc
versus NC, outperforming previous methods.
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INTRODUCTION
Alzheimer’s disease (AD) is a progressive, degen-
erative brain disease and is the most common form
of dementia in adults aged 65 and older. Worldwide
prevalence of AD is expected to rise to over 100
million by 2050 [1]. Many studies provide evidence
suggesting that AD progresses by selective degenera-
tion of neuronal populations in several brain regions.
1Data used in preparation of this article were obtained from
the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
(http://adni.loni.usc.edu). As such, the investigators within the
ADNI contributed to the design and implementation of ADNI
and/or provided data but did not participate in analysis or writ-
ing of this report. A complete listing of ADNI investigators can
be found at: http://adni.loni.usc.edu/wp-content/uploads/how to
apply/ADNI Acknowledgement List.pdf
∗Correspondence to: Tanya Glozman, Department of Electrical
Engineering, 318 Campus Drive, Stanford, CA 94305, USA. Tel.:
+1 650 724 3333; E-mail: tanyagl@stanford.edu.
The hippocampus is one of the earliest structures to
be affected [2]. Mild cognitive impairment (MCI) is
a prodromal stage of AD with a conversion rate of
about 10% [3]. Studying why only certain individuals
with MCI develop AD is fundamental to understand-
ing the diseases and developing accurate prognostic
indicators.
Magnetic resonance imaging (MRI) of AD patients
reveals overall volume loss and shape changes in
specific brain structures, such as the hippocampus,
amygdala, corpus callosum, and other regions [4].
Fig. 1 shows a comparison of coronal and axial views
of T1-weighted MR scans: a healthy 79-year-old
female on the left, and a 74-year-old female diag-
nosed with AD on the right. The left hippocampi
and lateral ventricles are shown in detail on the
side panels. An overall tissue loss is apparent in
the late-stage AD patient. As neurons die, the brain
parenchyma shrinks, leading to passive enlargement
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Fig. 1. Overall tissue loss in the brain in AD patient (right) versus normal control (left) in coronal and axial views. The labeled regions are:
(a) lateral ventricles; (b) hippocampi; and (c) cerebral cortex.
of the brain ventricles. The purpose of this work
is to explore the subtle changes in shape of brain
structures most affected by AD. We develop shape
descriptors to capture and quantify these changes,
and test their efficacy as imaging biomarkers for
automatic classification of the following populations:
MCI patients who progressed to AD, AD patients,
and normal controls (NC). We are using a novel
3D shape descriptor, combining information from an
ensemble of brain structures and employing machine
learning. We evaluate our framework on a cohort
of 375 subjects available through the Alzheimer’s
Disease Neuroimaging Initiative (ADNI), compare
our results to other methods, and perform an anal-
ysis of the significance of the different features we
extract.
MATERIALS AND METHODS
Data
Data used in the preparation of this arti-
cle were obtained from the ADNI database
(http://adni.loni.usc.edu) [5]. The ADNI was
launched in 2003 as a public-private partnership,
led by Principal Investigator Michael W. Weiner,
MD. The primary goal of ADNI has been to test
whether serial MRI, positron emission tomography
(PET), other biological markers, and clinical and
neuropsychological assessment can be combined
to measure the progression of MCI and early AD).
For up-to-date information, see http://www.adni-
info.org. For comparison to other methods, we used
the same dataset as reported in [6] for three groups
of subjects: 162 cognitively normal elderly controls
(CN), 137 patients with AD, and 76 patients with
MCI who had converted to AD within 18 months
(MCIc). Demographic characteristics of the studied
population can be found in [6]. Details about data
pre-processing can be found in [5].
Processing framework overview
The main contribution of this work is a
computational framework that performs automatic
classification between different types of dementia,
namely MCIc and AD. We achieve top performance
in identifying the MCI patients that will convert to
Alzheimer’s within 18 months (MCIc). This section
is an overview of the processing steps. Details about
each step can be found in following subsections.
The inputs to our framework are the T1-weighted
MR images preprocessed with the Freesurfer image
analysis suite, freely available at http://freesurfer.net
[7]. Freesurfer outputs a 3D segmentation of 115 cor-
tical and subcortical brain structures according to the
Desikan-Killiany Atlas [8]. A subset of 8 regions
of interest (ROIs) (see below) is chosen and pro-
cessed separately: first, a projection of the ROI on
its principal plane is calculated (see Projections for
details). 2D shape descriptors are calculated for each
ROI, resulting in only 6 values per ROI (see Shape
descriptor calculation for details). We then construct
a 32-long feature vector for each subject by concate-
nating the feature values from all ROIs. These steps
are repeated for all subjects in the dataset.
Following this processing, the dataset is split in
half: 50% used for training the classifier, and the
rest is used for test and evaluation. To find the opti-
mal training parameters, we performed 5-fold cross
validation on the training set (see SVM Classica-
tion for details). Finally, we test our model on the
independent testing set, evaluate its performance and
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compare to other methods (see Comparison to other
methods for details). Additionally, in order to under-
stand the importance of each brain structure and its
derived features for the classification, we perform
feature analysis experiments (see Feature analysis
experiments for details).
Data preprocessing and ROI extraction
It is commonly accepted that at progressive stages
of AD, degeneration of brain tissue occurs, leading
to structural changes in several brain structures (see
[4] for a list of supporting research), including the
hippocampi and the ventricles [9]. In this work we
focus on a subset of these structures and choose the
following ROIs:
1. The hippocampi (left and right)
2. Inferior lateral ventricles (left and right)
3. 3rd Ventricle
4. Right lateral ventricle
5. Cerebral white matter (left and right)2
Each ROI is a volumetric shape represented as a set
of points {x()}N=1 where N is the number of voxels
in the ROI. Each point consists of three coordinates
[x()i , x()j , x()k ] , where [i, j, k] is the subjects’ native
coordinate space.
Projections
We use projections to reduce the dimensionality
of the data. For each ROI, we first find the principal
axes of the 3D shape using the NIPALS algorithm for
principal component analysis (PCA) [10]. We project
each ROI onto the plane spanned by the first two
principal components. Then, to calculate the projec-
tion, we first partition the 2D plane into H × W bins,
where the values of H and W are of the order of 20
to 40 pixels, unique for each ROI type, but kept the
same (normalized) across all subjects for the specific
ROI. The value of each pixel f (i, j) on the H × W
projection matrix is obtained by counting how many
points x˜() fall into the (i,j)th bin. More formally,
f (i, j) =
∑N
=1
{
x˜
()
i = i & x˜()j = j
}
maxi,jf (i, j)
, (1)
where {·} is the indicator function and the division by
maximal value is used for normalization. This allows
canonical representation of the different shapes, and
2Only the volume of these structures was part of the feature
vectors.
reduces the dimensionality of the data from a 3D grid
of up to 10000 points to a 2D image of up to 1000
pixels. The resulting 2D image can be viewed as a
distribution matrix, which captures the density of the
point distribution from a viewpoint determined by
the ROI self coordinate system (principal directions).
Fig. 2 shows an example of such projections.
Shape descriptor calculation
We encode the information of the 2D projection
image in a compact feature descriptor. In this work we
focused on moments [11] and entropy. Moments have
been widely used in statistics to describe the shape of
a probability density function, in computer vision to
describe the shape of objects, e.g., [12] and in classic
rigid-body mechanics to describe the distribution of
mass in a body. The equation for central moment of
order p + q is
μpq =
∑
i
∑
j
(i − ¯i)p(j − ¯j)qf (i, j) (2)
where f (i, j) is the image intensity at location (i, j),
and (¯i, ¯j) is the centroid of the image. A uniqueness
theorem by Hu [11] states that the moment sequence
μpq uniquely determines the original f (i, j). In prac-
tice, a few lower order moments are sufficient. In
this work, we have empirically determined that the
following moment set is sufficient for the ROI char-
acterization: {μ11, μ12, μ22}. Entropy of a 2D shape
is defined as:
e = −
∑
i
∑
j
f (i, j) logb f (i, j). (3)
Together, these features carry information about
the shape center of mass, its orientation, and amount
of uncertainty each pixel contributes to the overall
shape. In addition to these four features per ROI,
we estimate the volumes of the structures listed
above by counting the number of voxels in each
ROI. Thus, we have a total of five features per ROI:
{μ11, μ12, μ22, e, V} for ROIs 1-4 listed above. An
additional two features came from estimates of vol-
umes of the cerebral white matter in the left and right
hemispheres. Hence we have a total of 5*6 + 2 = 32
features per subject. The features were normalized
by the maximal value of each feature type across the
entire cohort.
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Support Vector Machine (SVM) classiﬁcation
SVM is a supervised learning algorithm widely
used in various scientific disciplines (e.g., [13, 14]).
A detailed description can be found in [15]. Given
a training set of size K: (xk, yk)k=1...K, where xk ∈
R
d are observations and yk ∈ {−1, 1} are the cor-
responding labels, an SVM classifier aims to find a
hyperplane that maximizes the separation between
the two classes labeled by {−1, 1}. The decision sur-
face for a linear SVM classifier is given by y(x) =
wTx − b. The use of a linear SVM allows us to later
use the learned weights of the different features to
understand which brain regions were mostly affected
by the disease. The feature weight vector w and bias
b are learned on the training set as the solution to an
optimization problem. We performed 5-fold cross-
validation on the training set to find the optimal
error-cost parameter. In the k-fold cross validation
method, the data are randomly partitioned into k sub-
sets. Each of the k iterations, (k-1) subsets are used to
train the classifier and the remaining data is used for
testing. The cost parameter which yielded the high-
est cross-validation accuracy is then used to train the
classifier on the full training set. The performance of
the resulting classifier is evaluated on the test set.
Many implementations of SVM are available, in
this work we used the LibLinear library [16].
Comparison to other methods
The data set was randomly split into two groups
of similar size: train and test sets, preserving the
age and sex distribution across sets. Two classi-
fication experiments were performed: NC versus
AD; NC versus MCIc. For each experiment, we
computed the number of true positives (TP), true
negatives (TN), false positives (FP), and false neg-
atives (FN). We evaluate the performance using the
following measures: classification accuracy, sensitiv-
ity, specificity, and d’ [17, 18]. Sensitivity is defined
as TP/(TP+FN), measuring the proportion of cor-
rectly identified patients; Specificity is defined as
TN/(TN+FP), measuring the proportion of correctly
identified controls; Classification error is defined as
(TP+TN) / (TP+TN+FP+FN), measures the propor-
tion of examples that are correctly labeled by the
classifier. d’ is a discriminability index widely used in
signal detection theory and psychology [19]. Defined
as d′ = z(Sensitivity) − z(FalseAlarmRate), where
False Alarm Rate is defined as FP / (FP+TN),
and function z(p), p ∈ [0, 1], is the inverse of the
cumulative Gaussian distribution; It measures the
overlap between the distributions of two classes in
standard deviation units. A value of 0 corresponds to
fully overlapping distributions, thus classification is
pure chance. Values above 1 indicating a good sep-
aration between the classes. Value of 4 corresponds
to almost no overlap. For a full description of this
evaluation measure, we refer the reader to [19].
Feature analysis experiments
As described above, to compare to other methods
we used the same partition of the data into train/test
set as described in [6]. However, predetermining the
train/test set does not allow exploration of classifier
performance on variable population. To do this, we
repeated the AD versus NC experiments on train/test
sets created by randomly partitioning the dataset 100
times. Due to the limited amount of data for this ran-
dom partitioning, we could not require the gender/age
balance to be preserved. Thus these experiments
were not used to evaluate the classifier performance,
but rather only to understand the weights distribu-
tion. Each experiment provided a classifier model
with weights assigned to each feature. These pro-
vide insight on the diagnosticity of the different brain
regions and their shape attributes in classification of
AD patients from the normal population. The results
from these experiments are reported below.
RESULTS
Brain structure shape changes as a result of AD
The shape of the hippocampi and the ventricles
changes as AD progresses [2, 9].
Fig. 2 compares the projection images of the left
hippocampi (left panel) and the left inferior lateral
ventricle (right panel) in a healthy control subject
(NC) and an AD patient. An overall reduction in
volume for the hippocampi and an overall increase
in volume for the ventricles is observed. Projection
images and the features we calculate on them capture
these changes as well as more subtle local patholog-
ical changes.
Comparison to other methods
We compared our results to a comparative study
by Cuingnet et al. [6], evaluating the performance
of several approaches using the same dataset of three
subject groups (NC, MCIc, and AD). In [6], no single
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Fig. 2. Change in shape of brain structures in AD manifested on projection images. (a) l. hippocampus 3D shape (upper panel) in NC
(left) and AD (right). (b) l. inf. lat. ventricle 3D shape (upper panel) in healthy control (left) and AD patient (right). Lower panel shows the
corresponding canonical view using our principal projections method.
method achieved a good performance across all clas-
sification tasks, thus comparison to top-performing
method was not possible. Instead, in Fig. 3, we
summarize the results of other methods as error-
bar plots and present the comparison of our single
framework results as a red bold circle. Our method
achieves good results on both tasks and outperforms
all other methods in NC versus MCIc classifica-
tion: the highest-performing methods on NC versus
MCIc classification task reached specificity above
85% but a sensitivity value between 51% and 73%.
Our method achieves specificity of 93.83% and
sensitivity of 75.68%. In NC versus AD classification
task our method achieved values similar to the highest
performing methods: 88.89% specificity and 70.59%
sensitivity. Our classification accuracy is 88.13% for
NC versus MCIc and 80.54% for NC versus AD. This
indicates the applicability of our method for an early
diagnosis of AD in MCI patients.
Diagnosticity of brain shape attributes
To describe the diagnosticity of different features
on various brain structures, we analyze the feature
weights learned on the training set. These are auto-
matically determined during the training process and
are indicative of the importance of the feature to the
classifier [20, 21]. In a sense, our framework auto-
matically prunes the feature space to find the most
diagnostic biomarkers, as well as identifies the struc-
tures most affected by the disease. Fig. 4 displays the
weights of the features ± their standard deviation. To
better visualize the importance of the different fea-
tures, they are sorted in a descending manner, most
discriminative on top. All features calculated on the
same ROI are displayed in the same color - see Fig-
ure legend for quick reference. Left hippocampus
automatically emerges as the brain structure most
affected by AD since most features calculated on
it received high weights. Indeed, MRI derived hip-
pocampal volume strongly correlates with severity of
AD pathology as well as memory impairment [22].
DISCUSSION
In the search for robust imaging biomarkers for
AD, a range of studies suggest that applying statisti-
cal learning techniques on structural MRI data may
yield good results in AD classification. A compre-
hensive review of these studies can be found in [6].
Previous work can be roughly categorized into two
groups depending on the types of features extracted
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Fig. 3. Comparison to other methods. D’, sensitivity, and specificity for NC versus AD and NC versus MCIc classification. Our method
(red dot) outperforms previous methods in NC versus MCIc classification, indicating applicability for identifying patients with higher risk
of conversion to AD.
Fig. 4. Diagnosticity for different shape attributes of variousROIs.Features sorted and numbered according to their respective descending
weights in AD versus NC classification. Feature number represents relative rank-order. Weights values suggest the relative significance of
the feature to the classifier, i.e., the diagnostic power of the feature. Colors correspond to different brain structures as outlined in the legend.
from MRI data. Voxel-based techniques use the most
basic information of the data - intensity values of the
voxels (i.e., the probability of a voxel belonging to
one of three tissue types: gray matter, white matter, or
cerebrospinal fluid) as the training data for the classi-
fier. Some examples of these works are [23, 24]. Most
methods, however, begin with segmentation of the
brain into different structures/tissues. Image process-
ing feature extraction techniques are then employed
to reduce the dimensionality of the imaging data prior
to the classification. These methods differ by the fea-
ture extraction methods, the considered ROIs and
the classification techniques. In [25] for example, all
brain structures are utilized in the classification: vox-
els are first grouped into regions by registration with a
labeled atlas. Intensity histograms of all ROIs are then
used as feature vectors, fed into a statistical learning
framework.
Recently, most attention has focused on the
ROI-based approach which analyzes the volume or
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shape of a specific brain structure. The hippocam-
pus has received most attention, with classification
based on volume or shape-related features. Exam-
ples to the latter are [26] and [27], where spherical
harmonics (SPHARM) coefficients calculated on
the hippocampi are used as a feature vector for
the classification. Some recent work has focused
on understanding the change in brain ventricles as
well [28–30]. These shape-related features are also
referred to as shape-descriptors as they describe
some attribute of the 3D shape. A comprehensive sur-
vey on shape representation can be found in [31]. A
comprehensive survey of 3D shape descriptors can
be found in [32].
In the context of machine learning, descriptors are
referred to as features, and a set of descriptors per
shape is referred to as feature vector. The most com-
mon and direct way to differentiate between NC,
AD, and MCI populations is the volumetric analy-
sis, in which volumes of different brain structures are
compared across subjects. These studies differ in the
chosen ROIs, the method by which the segmentation
of the ROIs is obtained, and the statistical methods
used for data analysis. Some examples are [33, 34]. A
limitation of the volume-based methods is the inabil-
ity to capture the more subtle shape changes which
happen on a local scale. This limitation is what our
work attempts to address.
A recent work [35] has utilized a classical com-
puter vision method [36] and kernel-SVMs for
classification of AD subjects and the brain regions
most related to the disease. They modified the Eigen-
Brain method first introduced by [37] and proved
its effectiveness in AD subject prediction and dis-
criminating affected brain regions on MRI data.
In another recent work [38], an average ’displace-
ment field’ is calculated between key-slices in the
MRI data between AD subjects and normal controls.
These displacement field images are then reduced
by principle component analysis and classification
is performed by three different SVM variants. This
method achieves an impressive classification accu-
racy on a subset of data from the OASIS dataset
(http://www.oasis-brains.org/).
Our work suggests a different approach—our focus
is not on the images directly, but rather on the shapes
of brain structures affected by AD. The features we
derive are shape based and thus capture the subtle
changes in tissue degeneration of an ensemble of
brain structures.
Identifying MCI subjects that are prone to con-
vert to clinical AD is crucial in developing efficient
early prognostic indicators and treatment plans that
may delay the onset of cognitive and behavioral
symptoms and ultimately improve the quality of life
for AD patients and their caregivers. In this paper,
we described a fully automatic framework for clas-
sification of AD, MCIc, and normal controls. We
incorporate shape information from an ensemble of
regions of interests in the brain and utilize machine
learning approach to build a classifier for each of these
populations. The framework is modular, allowing a
user-defined choice of ROIs and feature descriptors.
In this work we chose to limit the number of structures
and focused on the hippocampi and the ventricles.
Our framework achieves classification accuracy of
88.13% for NC versus MCIc outperforming other
methods. We believe that several factors contribute
to this improvement: (1) using an ensemble of ROIs
rather than using a single ROI (e.g., hippocampus)
or the whole brain data. The ROIs we chose in this
study are the structures we believe manifest most
shape change in AD; (2) using shape descriptors
rather than voxel value data. This allowed us to use
a compact descriptor per subject - only 32 numbers.
Given the modest amount of data available for train-
ing and evaluation, using compact descriptor benefits
the classifier learning and avoids overfitting.
The descriptors we used in this work are simple to
compute, allow compact representation of the shape,
and are effective for classification as they capture the
subtle shape changes caused by tissue degeneration.
A vast variety of other shape representation exists
(see [31] for a comprehensive survey) and may be
explored in future work.
In addition to classification, and perhaps more
important, is the ability of our framework to auto-
matically identify the structures most affected by the
disease. We explored the discriminative power of the
different structures and their shape attributes. The
hippocampus was automatically found to be the most
important structure for the classifier, a notion well
supported by the literature. We are encouraged by
these results and in future development of this frame-
work we plan to build upon this ability and expand the
ROI inputs to identify other potential affected areas.
Utilization of this framework in identification of most
affected structures in other neurological disorders is
also an exciting avenue to explore.
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